Sollentuna, Sweden

Jan Vågberg


 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Solna, SE (2023)
  • Sollentuna, SE (1996 - 2024)

Company Filing History:


Years Active: 1996-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: Innovations of Jan Vågberg: A Pioneering Inventor in Pharmaceutical Compounds

Introduction

Jan Vågberg, an accomplished inventor based in Sollentuna, Sweden, has made significant contributions to the field of pharmaceutical chemistry with a total of nine patents to his name. His innovative work primarily focuses on developing processes for the preparation of specialized compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are groundbreaking developments in the stereoselective preparation of chiral compounds. One notable patent describes a process for synthesizing chiral 2-[(hetero) arylalkylsulfanyl]pyrimidines, outlining a method to produce compounds that are pivotal in pharmaceutical formulations. Additionally, Vågberg has patented phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines, which are instrumental in treating various diseases associated with elevated levels of CX3CR1 and/or CX3CL1. These compounds have therapeutic implications in managing conditions such as inflammation, autoimmune diseases, and even cancer.

Career Highlights

Throughout his career, Jan Vågberg has worked with notable companies, including Kancera AB and Betagenon AB. His role in these organizations reflects his dedication to advancing scientific knowledge and improving patient outcomes through innovative pharmaceutical solutions. Vågberg's extensive patent portfolio is a testament to his inventive spirit and commitment to research.

Collaborations

Vågberg's success can also be attributed to his collaborations with respected colleagues, such as Styrbjörn Byström and Elisabeth Olsson. These partnerships have fostered an environment conducive to innovation and have facilitated the advancement of critical pharmaceutical research projects.

Conclusion

In summary, Jan Vågberg stands out as a leading inventor in the pharmaceutical domain, with a strong portfolio of patents that demonstrate his expertise and creativity in developing therapeutic compounds. His contributions not only highlight his skills as an inventor but also mark significant advancements in medical science, showcasing the vital role of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…